84192-4-RR

antibody from Proteintech Group

Targeting: MKI67 MIB-1, PPP1R105

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

84192-4-RR

Provider

Proteintech Group

Product name

Ki-67 monoclonal antibody

Antibody type

Recombinant

Description

Ki-67 monoclonal antibody (Catalog no. 84192-4-RR) is a rabbit recombinant antibody that shows reactivity with human and has been validated for the following applications: WB, IHC, IF/ICC, IF-P, ELISA

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

2.41E+12

References

Submitted references

Hypoxic Reprogramming of ACOX1-Driven HSP90AB1 Crotonylation Stabilizes Thioredoxin to Orchestrate Redox Homeostasis in Oral Squamous Cell Carcinoma.

Yin X, Zhang Y, Zhang Y, Zhou M, Zhang J, Wang Z, Xu W, Song C, Ran J, Lin L, Luo X, Han W
Research (Washington, D.C.) 2026;9:1129

---

An integrated approach combining computational analyses and experimental validation deciphers the mechanism and active substance basis of Huazhuo Ningfu decoction in treating psoriasis.

Guan Z, Han M, Wang X, Ma W, Shi S, Jiang H, Sun J, Cao P, Man S
Naunyn-Schmiedeberg's archives of pharmacology 2026 Mar;399(5):7183-7214

---

Time-resolved multiomics profiling reveals chromatin O-GlcNAc modification promotes senescence-associated transcriptional program.

Zhang N, Zhao R, Zhong X, Dong Q, Liu Y, Yu K, Han L, Meng F, Wu J, Chen Q, Li X, Chen Q, Zhang K, Huang H, Zhang J, Wu S, Ren Y, Wang W, Liu Y
Nature communications 2026 Jan 8;17(1):1406

---

FAM64A Potentiates Bladder Carcinoma Tumorigenesis and Metastasis Through PI3K/mTORC2/AKT Pathway Activation.

Zhu T, Liufu C, Yin C, He J, Luo J, Shi B, Wang Y
Cancers 2026 Feb 6;18(3)

---

S100A10 promotes glycolysis and malignant progression of CCA by activating the HK2/ERK signaling pathway.

Wang Y, Chen W, Liu W, Zhang X, Wang Y, Dai N
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026 Feb 17;

---

The promoting roles of GLP1R and GIPR in stemness maintenance and multiple lineage-specific differentiation of PDLSCs.

Shen Y, Zhang M, Yang T, Wu Y, Qiu Y, Zhang L, Li F, Chen M, Chen Q, Wei W, Li H, Shen Y
Cellular & molecular biology letters 2026 Feb 11;31(1):22

---

Homoharringtonine suppresses gastric cancer progression by targeting PI3K/ AKT/FOXO pathway and impairing the GSH-GPX4 antioxidant axis.

Wang X, Ying X, Lv S, Ru S, Jin H, Zhang Y, Guo J
Cancer chemotherapy and pharmacology 2026 Apr 29;96(1)

---

FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway.

Hu Z, Li F, Hu C, Shan Q, Tang Z, Jiang M, Yi X, Chen X, Jin L, Wang X, Wang Y
Frontiers in bioengineering and biotechnology 2025;13:1729166

---

SLC8A1-AS1 inhibits oral squamous cell carcinoma by regulating the miR-1305/ESRRG axis.

Pan S, Ding F, Hu M, Xue H
Discover oncology 2025 Sep 26;16(1):1732

---

RRM2-mediated inhibition of GPX4 ubiquitination: A novel mechanism for ferroptosis suppression and reduced cisplatin sensitivity in small cell lung cancer.

You L, Su Z, Xie J, He Y, Zhi S, Zheng S, Wang M, Li D, Liu Z
Cellular signalling 2025 Nov;135:112034

---

Tenascin-C-enriched extracellular vesicles contribute to osteosarcoma progression via regulation of the angiotensin II receptor type 1 pathway.

Wang L, Liu K, Lyu L, Yin Z
Journal of molecular histology 2025 Nov 4;56(6):366

---

RANBP1 promotes immune evasion in triple-negative breast cancer by suppressing T cell infiltration via the miR-769-5p/PRUNE2 axis.

Song P, Liu X, Qiu H, Cao Y, Liu J, Zheng X, Yao S, Cao M
Discover oncology 2025 Nov 4;16(1):2026

---

Apigenin inhibits recurrent bladder cancer progression by targeting VEGF-β.

Shi ZD, Liu Y, Tao ZQ, Chao L, Zhang ZG, Sun F, Yuan FK, Ma QF, Li ZY, Chen ZS, Wu SY, Han CH
Cancer letters 2025 Jun 28;620:217676

---

ACNO hydrogel enhances diabetic wound healing by modulating the Bcl-2/Bax/Caspase-3/PARP pathway.

Ye P, Wu X, Gu R, Zhu H, Chen J, Dai Y, Zhang Q, Tang M, Nie X
International immunopharmacology 2025 Feb 6;147:113997

---

Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment.

Zhao Q, Zeng R, Bi T, Yang X, Wang T, Chen L, Huang J, Dai X, Xu H, Sun Q, Liu Z
ACS applied materials & interfaces 2025 Dec 17;17(50):67595-67608

---

The oncogenic role of SPOCK1 in lung carcinoma by promoting immune evasion and its related mechanisms.

Lv G, Chen J, Wei D, Zhang W, Xie W, Yang S
Cytotechnology 2025 Aug;77(4):138

---

NUTF2 Promotes Proliferation of Oral Squamous Cell Carcinoma Through PI3K/AKT Signaling Pathway.

Chen Z, Zhao Z, Xu T, Zou F, Yang Y, Lu P, Chen Y, Zhu Z, He Y, Wu Y, Ding X, Song X
Oral diseases 2025 Aug;31(8):2441-2455

---

Epstein-Barr virus-coded miR-BART19-3p promotes proliferation of EBV-associated gastric cancer by inhibiting GADD45B.

Yang J, Han Y, Zeng B, Hu G, Liu Z, Gan R
Journal of translational medicine 2025 Aug 25;23(1):956

---

CX26 promotes pancreatic cancer progression by competitively inhibiting interaction of c-Myc with PSMD2 and enhancing c-Myc stability.

He C, Tang C, Guo J, Yin X, Zhu Q, Fang C
Journal of translational medicine 2025 Aug 19;23(1):939

---

Hypoxic Cancer Cells-Derived Exosomes Strengthen the Development of Cancer Stem Cell-Like Properties Through Delivering LINC00665 in Thyroid Cancer Cells.

Zhou M, Peng C, Zhang Q, Tong Y
Cell biology international 2025 Apr;49(4):384-396

---

Thermal proteome profiling (TPP) reveals NAMPT as the anti-glioma target of phenanthroindolizidine alkaloid PF403.

Li F, Zhang Z, Shi Q, Wang R, Ji M, Chen X, Li Y, Liu Y, Yu S
Acta pharmaceutica Sinica. B 2025 Apr;15(4):2008-2023